Considerations about a doublet versus triplet therapy

Thanks for sharing that. I think the key point is in the text before the table:

1. Doublet therapy for low-volume (oligometastatic) advanced prostate cancer
2. Triplet therapy for high-volume (polymetastatic) advanced prostate cancer.

It aligns well with what we've been discussing and referencing here in the forum for the last while. With the doublet therapy, you'd also have radiation treatment to the individual metastases and the prostate itself.

I thought the table at the bottom with side effects was pretty interesting for people that are not familiar with the different treatment treatments.

Yes, this is clear and consise. The table is a nice reference to see all. The Docetaxel edema syrprised us as not everyone experiences it - will probably post about it in another thread.

Just fyi, my husband had no edema with docetaxel.

That is great to hear! The fewer the side effects, the better, right?

Just to make this more clear

AR antagonists: Enzalutamide, Apalutamide, and Darolutamide

GnRH antagonist drugs like abarelix, degarelix, elagolix, ganirelix, linzagolix, and relugolix These are ADT type drugs